Coenzyme Q10 (CoQ10) is nature’s biochemical spark plug. CoQ10 is an organic compound which is naturally produced by the body in small quantities and is used in cellular respiration and energy production in mammals. Produced commercially, CoQ10 is made by fermenting beets and sugar cane with yeast. It is consumed as a dietary supplement for its antioxidant properties, and is often promoted as a preventive agent for cardiovascular and neurological diseases, infertility, and cancer.
In oncology there is great interest in CoQ10. It is generally a safe supplement to take but it may be sensible to avoid taking CoQ10 during radiotherapy or chemotherapy as CoQ10 and other antioxidant vitamins might interfere with cancer treatment. This is because research in mice suggests that antioxidant supplements, including CoQ10 may antagonize the effect of radiation therapy. As a result, Oncologists also guide against taking CoQ10 until a few weeks after chemotherapy as well. Due to ethical issues, human studies are lacking to support this evidence however a lab based study showed that CoQ10 did not affect the ability of doxorubicin chemotherapy to kill cancer cells..
CoQ10 supplements may be helpful for some people with advanced cancer who are not on treatment. One study using a mixture of CoQ10, vitamin C, selenium, folic acid and beta carotene found advanced cancer patients lived more than 40% longer than the researchers predicted. The treatments also caused very few side effects.. In addition, two early case reports describe efficacy for diagnosed breast cancer patients as the tumours regressed after taking CoQ10 supplements.[4,5] Since then a lab based study on breast cancer cells have shown that taking CoQ10 positively effects the molecules which effect are linked to cell invasion and metastasis.
It is thought that low levels of circulating CoQ10 may be a useful predictor of cancer risk. In the multiethnic cohort study, scientists assessed the association of circulating CoQ10 levels with prostate cancer risk, using prediagnostic blood samples. The results show the possibility that moderate levels of circulating CoQ10 may be optimal for the reduction of prostate cancer risk.
In melanoma however, CoQ10 plasma levels may be even more useful. A prospective study of patients with melanoma was conducted to assess the usefulness of CoQ10 plasma levels in predicting the risk of metastasis and the duration of the metastasis-free interval. Findings show that baseline plasma CoQ10 levels are a powerful and independent prognostic factor that can be used to estimate the risk for melanoma progression. Baseline levels are also useful in estimating the risk for pancreatic cancer progression. Like in melanoma and pancreatic cancer, low levels of circulating CoQ10 may also predict breast cancer risk in Chinese women, although in the population of women studied, they all had low levels. The risk of breast cancer may therefore only relate to chronically low levels.
In a study of rats with induced hepatocellular carcinoma, CoQ10 in a dose of 0.4mg/kg/day given for 4 weeks reversed damage and prevented progression. It was concluded that CoQ10 may represent a potential therapeutic option for liver carcinogenesis. The same effects are yet to be seen in human trials with liver cancer.
Studies in mice indicate CoQ10 has antioxidant and neuroprotective properties.[12,13] Small neuroprotective effects of CoQ10 have also been reported in a study of patients with progressive supranuclear palsy as well as those with early Parkinson’s disease. Those with midstage Parkinson’s disease do not derive benefit from taking CoQ10. A mixture of antioxidants, including CoQ10, vitamins C, E, and lipoic acid appear to be ineffective against Alzheimer’s disease prevention.
CoQ10 has been shown to confer benefits in patients with coronary artery disease and may also be useful in patients with congestive heart failure. Coenzyme Q10 has been shown to have effects on the endothelial function. It is also known that coenzyme Q10 is a powerful anti-oxidant, mainly against lipid peroxidation. Reports have shown that CoQ10 also reduces inflammatory responses and also does this in those with diabetes. It is reported that the endogenous production of coenzyme Q10 decreases after the age of 20, and the myocardial production is reduced to half at the age of 80.
Female fecundity starts declining at age 32 and decreases more rapidly after age 37. This decrease in the probability of conception occurs in spite of continuing ovulatory cycles. Impaired mitochondrial performance created by suboptimal CoQ10 availability can drive age-associated oocyte deficits causing infertility, as shown by a study where women donated their eggs for experimentation. In rats CoQ10 supplementation may protect ovarian reserve by counteracting both mitochondrial ovarian ageing and physiological programmed ovarian ageing.
CoQ10 supplementation may increase sperm motility in asthenozoospermic men. Dietary CoQ10 intake from foods alone may not be sufficient to optimise semen parameters.
CoQ10 is structurally similar to vitamin K and therefore should be avoided by people taking warfarin as it can have an antagonistic action.[31,32]
- Lund EL, Quistorff B, Spang-Thomsen M et al. Effect of radiation therapy on small-cell lung cancer is reduced by ubiquinone intake. Folia Microbiol 1998;4:505-6.
- Greenlee H, Shaw J Lau YK et al. Lack of effect of Coenzyme Q10 on doxorubicin cytotoxicity in breast cancer cell cultures. Intergr Cancer Ther 2012;11(3):243-250.
- Hertz N, Lister RE. Improved Survival in Patients with End-Stage Cancer Treated with Coenzyme Q10 and other Antioxidants: A Pilot Study, Journal of International Medical Research. 2009;37 (6) 1961-1971.
- Lockwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochem Biophys Res Comm 1994;199: 1504-8
- Lockwood K, Moesgaard S, Yamamoto T, et al. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastasis. Biochem Biophys Res Comm 1995; 212:172-7.
- Bahar M, Khaghani S et al. Exogenous Coenzyme Q10 modulates MCF-7 cell line as a breast cancer cellular model. Nutr J 2010;9, 62
- Chai W, Cooney RV et al. Coenzyme Q10 levels and prostate cancer risk: the multiethnic cohort study Cancer Epidemiol Biomarkers Prev 2011;20(4):708-10.
- Rusciani L, Proietti I, Rusciani A et al. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol 2006;54(2):234-41.
- Ito T, Ito M, Sheiozawa J et al. Expression of MMP-1 in human pancreatic carcinoma: raltionship with progniostic factor. Mod Pathol 1999;12:669-74.
- Cooney RV, Dai Q et al. Low plasma coenzyme Q(10) levels and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 2011;20(6):1124-30.
- Fouad AA, Al-Mulhim AS, Jresat I. Therapeutic effect of coenzyme Q10 against experimentally-induced hepatocellular carcinoma in rats. Environ Toxicol Pharmacol 2013. 35(1):100-8.
- Kalayci M, Unal MM, Gul S, et al. The effect of Coenzyme Q10 on ischemia and neuronal damage in an experimental traumatic brain injury model in rats. BMC Neurosci 2011;12(1):75.
- Dumont M, Kipiani K, Yu F, et al. Coenzyme Q10 Decreases Amyloid Pathology and Improves Behavior in a Transgenic Mouse Model of Alzheimer’s Disease. J Alzheimers Dis 2011;27(1):211-23.
- Stamelou M, Reuss A, Pilatus U, et al. Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord 2008;23(7):942-949.
- Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early parkinson disease. Arch Neurol 1998; 4:505-6.
- Storch A, Jost WH, Vieregge P, et al. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol 2007;64(7):938-944.
- Galasko DR, Peskind E, Clark CM, et al. Alzheimer’s Disease Cooperative Study. Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures. Arch Neurol 2012;69(7):836-41.
- Tiano L, Belardinelli R, Carnevali P et al. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 2007;28(18):2249-2255.
- Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. Am J Clin Nutr 2013; 97(2):268-75.
- Gao L, Mao Q, Cao J, Wang Y, Zhou X, Fan L. Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials. Atherosclerosis. 2012;221(2):311–6. Epub 2011/11/18. pmid:22088605.
- Bullon P, Roman-Malo L, Marin-Aguilar F, Alvarez-Suarez JM, Giampieri F, Battino M, et al. Lipophilic antioxidants prevent lipopolysaccharide-induced mitochondrial dysfunction through mitochondrial biogenesis improvement. Pharmacol Res. 2015;91:1–8. pmid:25447593.
- Lee BJ, Tseng YF, Yen CH, Lin PT. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutr J. 2013;12(1):142. pmid:24192015; PubMed Central PMCID: PMC4176102.
- Brauner H, Luthje P, Grunler J, Ekberg NR, Dallner G, Brismar K, et al. Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity. Clin Exp Immunol. 2014;177(2):478–82. pmid:24593795; PubMed Central PMCID: PMC4226598.
- Kalen A, Appelkvist EL, Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids. 1989;24(7):579–84. Epub 1989/07/01. pmid:2779364.
- O’Connor KA, Holman DJ, Wood JW.Declining fecundity and ovarian ageing in natural fertility populations. Maturitas. 1998 Oct 12; 30(2):127-36.
- te Velde ER, Pearson PLThe variability of female reproductive ageing. Hum Reprod Update. 2002 Mar-Apr; 8(2):141-54.
- Ben-Meir A, Burstein E, Borrego-Alvarez A, et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell. 2015;14(5):887-95.
- Özcan P, Fıçıcıoğlu C, Kizilkale O, et al. Can Coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage?. J Assist Reprod Genet. 2016;33(9):1223-30.
- Balercia G, Buldreghini E, Vignini A, et al. Coenzyme Q (10) treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril 2009; 91(5):1785-92.
- Tiseo BC, Gaskins AJ, Hauser R, Chavarro JE, Tanrikut C, EARTH Study Team. Coenzyme Q10 Intake From Food and Semen Parameters in a Subfertile Population. Urology. 2016;102:100-105.
- Fuke C, Krikorian SA, Couris RR. Coenzyme Q10: a review of essential functions and clinical trials. US Pharmacist 2000;25:28-41.
- Shalansky S, Lynd L, Richardson K, et al. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy 2007; 27(9):1237-47.